These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 32474362)

  • 1. Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-19.
    Kishfy L; Casasola M; Banankhah P; Parvez A; Jan YJ; Shenoy AM; Thomson C; AbdelRazek MA
    J Neurol Sci; 2020 Jul; 414():116943. PubMed ID: 32474362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient.
    Princiotta Cariddi L; Tabaee Damavandi P; Carimati F; Banfi P; Clemenzi A; Marelli M; Giorgianni A; Vinacci G; Mauri M; Versino M
    J Neurol; 2020 Nov; 267(11):3157-3160. PubMed ID: 32583053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posterior Reversible Encephalopathy Syndrome in Patients with Coronavirus Disease 2019: Two Cases and A Review of The Literature.
    Anand P; Lau KHV; Chung DY; Virmani D; Cervantes-Arslanian AM; Mian AZ; Takahashi CE
    J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105212. PubMed ID: 33066908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postpartum consciousness disturbance: can covid-19 cause posterior reversible encephalopathy syndrome?
    López Pérez V; Cora Vicente J; Echevarría Granados C; Salcedo Vázquez ML; Estol F; Tebar Cuesta MY
    Rev Esp Anestesiol Reanim (Engl Ed); 2020 Nov; 67(9):511-515. PubMed ID: 33036761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pressing Issues in COVID-19: Probable Cause to Seize SARS-CoV-2 for Its Preferential Involvement of Posterior Circulation Manifesting as Severe Posterior Reversible Encephalopathy Syndrome and Posterior Strokes.
    D'Amore F; Vinacci G; Agosti E; Cariddi LP; Terrana AV; Vizzari FA; Mauri M; Giorgianni A
    AJNR Am J Neuroradiol; 2020 Oct; 41(10):1800-1803. PubMed ID: 32732268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemorrhagic Posterior Reversible Encephalopathy Syndrome as a Manifestation of COVID-19 Infection.
    Franceschi AM; Ahmed O; Giliberto L; Castillo M
    AJNR Am J Neuroradiol; 2020 Jul; 41(7):1173-1176. PubMed ID: 32439646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early postmortem brain MRI findings in COVID-19 non-survivors.
    Coolen T; Lolli V; Sadeghi N; Rovai A; Trotta N; Taccone FS; Creteur J; Henrard S; Goffard JC; Dewitte O; Naeije G; Goldman S; De Tiège X
    Neurology; 2020 Oct; 95(14):e2016-e2027. PubMed ID: 32546654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dramatic improvement after tocilizumab of severe COVID-19 in a child with sickle cell disease and acute chest syndrome.
    Odièvre MH; de Marcellus C; Ducou Le Pointe H; Allali S; Romain AS; Youn J; Taytard J; Nathan N; Corvol H
    Am J Hematol; 2020 Aug; 95(8):E192-E194. PubMed ID: 32358817
    [No Abstract]   [Full Text] [Related]  

  • 9. Transient cortical blindness in COVID-19 pneumonia; a PRES-like syndrome: Case report.
    Kaya Y; Kara S; Akinci C; Kocaman AS
    J Neurol Sci; 2020 Jun; 413():116858. PubMed ID: 32387762
    [No Abstract]   [Full Text] [Related]  

  • 10. Posterior reversible encephalopathy syndrome - A pathology that should not be overlooked in the era of COVID-19.
    Ioan P; Ribigan AC; Rusu O; Bratu IF; Badea RS; Antochi F
    Am J Emerg Med; 2022 Jun; 56():393.e5-393.e8. PubMed ID: 35346531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 receptor antagonist therapy to treat SARS-CoV-2 driven inflammatory syndrome in a kidney transplant recipient.
    Allam SR; Dao A; Madhrira MM; Antiporta PB; Nair RR; Guiteau JJ; Reyad AI
    Transpl Infect Dis; 2020 Aug; 22(4):e13326. PubMed ID: 32406985
    [No Abstract]   [Full Text] [Related]  

  • 12. Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19.
    Gade AR; Alavala H; Allam SR
    Kidney Int; 2020 Oct; 98(4):1054. PubMed ID: 32650019
    [No Abstract]   [Full Text] [Related]  

  • 13. Posterior reversible encephalopathy syndrome in patients with COVID-19.
    Parauda SC; Gao V; Gewirtz AN; Parikh NS; Merkler AE; Lantos J; White H; Leifer D; Navi BB; Segal AZ
    J Neurol Sci; 2020 Sep; 416():117019. PubMed ID: 32679347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine release syndrome in severe COVID-19.
    Moore JB; June CH
    Science; 2020 May; 368(6490):473-474. PubMed ID: 32303591
    [No Abstract]   [Full Text] [Related]  

  • 15. Tocilizumab for COVID-19: a real 'miracle drug'?
    Nasim S; Hashmi SH; Azim D; Kumar S; Nasim J
    Infect Dis (Lond); 2020 Sep; 52(9):681-682. PubMed ID: 32644027
    [No Abstract]   [Full Text] [Related]  

  • 16. The complement inhibitors in COVID-19: future expectations.
    Korotchaeva Y; Kozlovskaya N; Bobrova L; Kamyshova E; Demyanova K; Moiseev S
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6480-6481. PubMed ID: 32633332
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neurological Manifestations of COVID-19: Meningoencephalitis and Encephalopathy].
    Nakajima H
    Brain Nerve; 2020 Oct; 72(10):1031-1037. PubMed ID: 33051388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 6-blockade treatment for severe COVID-19 in two patients with multiple myeloma.
    Chaidos A; Katsarou A; Mustafa C; Milojkovic D; Karadimitris A
    Br J Haematol; 2020 Jul; 190(1):e9-e11. PubMed ID: 32369612
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurological emergencies associated with COVID-19: stroke and beyond.
    Agarwal A; Pinho M; Raj K; Yu FF; Bathla G; Achilleos M; ONeill T; Still M; Maldjian J
    Emerg Radiol; 2020 Dec; 27(6):747-754. PubMed ID: 32778985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tocilizumab for Hemophagocytic Syndrome in a Kidney Transplant Recipient With COVID-19.
    Faguer S; Del Bello A; Abravanel F; Nicolau-Travers ML; Kamar N
    Ann Intern Med; 2020 Sep; 173(6):501-503. PubMed ID: 32432518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.